Filing Flows › Nautilus Biotechnology (NAUT) › Stock forecast & fair value
Nautilus Biotechnology (NAUT) stock forecast and price target
Nautilus Biotechnology (NAUT) trades at $2.23. The analysts' price target is $4.00 (+79%).
Nautilus Biotechnology's latest quarter
Nautilus Biotechnology, Q3 2026: revenue $234K, net loss $15.6M, operating cash flow −$13.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NAUT stock?
The analysts' 12-month target is $4.00, +79% from $2.23. The average rating is strong buy.
Does Nautilus Biotechnology usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is NAUT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.